Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Risankizumab (by subcutaneous injection) for Active Psoriatic Arthritis After Inadequate Control or Intolerance to Conventional Drugs Risankizumab (BI 655066; Skyrizi; ABBV 066) Psoriatic arthritis Dermatology , Rheumatology 2017 View  |  Download
Risankizumab (by Subcutaneous Injection) for Moderate to Severe Chronic Plaque Psoriasis Risankizumab (BI 655066; Skyrizi; ABBV 066) Plaque psoriasis Dermatology 2017 View  |  Download
Risankizumab for moderate to severe crohn’s disease Risankizumab (BI 655066; Skyrizi; ABBV 066) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications